WallStSmart
ARTL

Artelo Biosciences Inc

NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY

$3.49
+2.35% today

Updated 2026-04-30

Market cap
$3.79M
P/E ratio
P/S ratio
EPS (TTM)
$-37.56
Dividend yield
52W range
$3 – $86
Volume
4.2M

Artelo Biosciences Inc (ARTL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$0.00$0.00$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00$0.00$0.00
Gross margin
R&D$1.25M$1.25M$1.25M$1.25M$1.09M$1.92M$2.84M$4.32M$5.70M$5.99M$5.42M
SG&A$15269.00$15241.00$29690.00$232789.00$1.09M$2.12M$2.77M$4.60M$5.96M$4.23M$4.12M$5.98M
Operating income$-15269.00$-15241.00$-29690.00$-232789.00$-2.34M$-3.21M$-4.69M$-7.44M$-10.29M$-9.93M$-10.11M$-11.40M
Operating margin
EBITDA$-15269.00$-15241.00$-29690.00$-232789.00$-2.34M$-4.22M$-4.69M$-7.44M$-10.08M$-9.93M$-10.11M$-12.54M
EBITDA margin
EBIT$-15269.00$-15241.00$-29690.00$-232789.00$-2.34M$-4.22M$-4.69M$-7.44M$-10.29M$-9.93M$-10.11M$-12.69M
Interest expense$0.00$0.00$0.00$2100.00$0.00$0.00$0.00$0.00$5000.00$0.00$0.00$194000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-15269.00$-15241.00$-29690.00$-234889.00$-2.34M$-2.17M$-4.66M$-7.44M$-10.08M$-9.29M$-9.83M$-12.88M
Net income growth (YoY)+0.2%-94.8%-691.1%-897.7%+7.3%-114.3%-59.8%-35.6%+7.9%-5.8%-31.1%
Profit margin